Therapeutics Invest Information

Earnings
TG Therapeutics (TGTX) Set to Announce Quarterly Earnings on Monday Nov 2, 2024
Stocks
Atossa Therapeutics Receives Buy Rating from HC Wainwright Oct 31, 2024
Companies
Abeona Therapeutics Receives Buy Rating from HC Wainwright Oct 31, 2024
Earnings
Enliven Therapeutics Reports Encouraging Phase 1 Results for ELVN-001 in Chronic Myeloid Leukemia Treatment Sep 29, 2024
Companies
Pliant Therapeutics Showcases Promising Bexotegrast Program Data at ERS International Congress 2024 Sep 10, 2024
Companies
Unicycive Therapeutics Announces Presentation at H.C. Wainwright Global Investment Conference Sep 6, 2024
Companies
Addex Therapeutics Faces Setback as Partner Halts ADX71149 Development in Epilepsy Jul 22, 2024
Biotechnology
Gain Therapeutics Presents Key Data on GT-02287 at FENS Forum 2024 Jun 27, 2024
Companies
Anavex Life Sciences Bolsters Leadership to Enhance Global Healthcare Delivery May 23, 2024
Companies
Cognition Therapeutics Announces Completion of Patient Enrollment for CT1812 Phase 2 Study in Dementia with Lewy Bodies Apr 29, 2024
Markets
SpringWorks Therapeutics Announces Presentation at J.P. Morgan Healthcare Conference Dec 21, 2023
Companies
Xilio Therapeutics Commences Phase 1 Trial for XTX101 in Combination Therapy for MSS CRC Dec 7, 2023
Stocks
Rosen Law Firm Urges Brainstorm Cell Therapeutics Inc. Investors with Losses to Act Before Deadline Nov 12, 2023
Stocks
TG Therapeutics TGTX Upgraded to 'Buy' by StockNews.com Amid Positive Analyst Sentiment Nov 12, 2023
Investment
Intellia Therapeutics Surpasses Q3 Earnings Expectations and Announces Progress in Gene-Editing Pipeline Nov 11, 2023
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin Nov 9, 2023
Catalyst Pharmaceuticals Delivers Mixed Q3 Results While Raising 2023 Outlook Nov 9, 2023